BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Seol W, Kim H, Son I. Urinary Biomarkers for Neurodegenerative Diseases. Exp Neurobiol 2020;29:325-33. [PMID: 33154195 DOI: 10.5607/en20042] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Xu M, Yang A, Xia J, Jiang J, Liu CF, Ye Z, Ma J, Yang S. Protein Glycosylation in Urine as a Biomarker of Diseases. Transl Res 2022:S1931-5244(22)00174-8. [PMID: 35952983 DOI: 10.1016/j.trsl.2022.08.001] [Reference Citation Analysis]
2 Gong X, Zhang H, Liu X, Liu Y, Liu J, Fapohunda FO, Lü P, Wang K, Tang M. Is liquid biopsy mature enough for the diagnosis of Alzheimer’s disease? Front Aging Neurosci 2022;14:977999. [DOI: 10.3389/fnagi.2022.977999] [Reference Citation Analysis]
3 Li RX, Ma YH, Tan L, Yu JT. Prospective Biomarkers of Alzheimer's Disease: A Systematic Review and Meta-analysis. Ageing Res Rev 2022;:101699. [PMID: 35905816 DOI: 10.1016/j.arr.2022.101699] [Reference Citation Analysis]
4 Jung DH, Son G, Kwon O, Chang K, Moon C. Non-Invasive Nasal Discharge Fluid and Other Body Fluid Biomarkers in Alzheimer’s Disease. Pharmaceutics 2022;14:1532. [DOI: 10.3390/pharmaceutics14081532] [Reference Citation Analysis]
5 Khachornsakkul K, Tiangtrong A, Suwannasom A, Sangkharoek W, Jamjumrus O, Dungchai W. Distance-based β-amyloid protein detection on PADs for the scanning and subsequent follow-up of Alzheimer's disease in human urine samples. Analyst 2022;147:695-703. [PMID: 35076036 DOI: 10.1039/d1an01605a] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Song Z, Qu Y, Xu Y, Zhang L, Zhou L, Han Y, Zhao W, Yu P, Zhang Y, Li X, Qin C. Microarray microRNA profiling of urinary exosomes in a 5XFAD mouse model of Alzheimer's disease. Animal Model Exp Med 2021;4:233-42. [PMID: 34557649 DOI: 10.1002/ame2.12175] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Kim KY, Shin KY, Chang KA. Brain-Derived Exosomal Proteins as Effective Biomarkers for Alzheimer's Disease: A Systematic Review and Meta-Analysis. Biomolecules 2021;11:980. [PMID: 34356604 DOI: 10.3390/biom11070980] [Reference Citation Analysis]
8 Giri B, Seamon M, Banerjee A, Chauhan S, Purohit S, Morgan J, Baban B, Wakade C. Emerging urinary alpha-synuclein and miRNA biomarkers in Parkinson's disease. Metab Brain Dis 2021. [PMID: 33881722 DOI: 10.1007/s11011-021-00735-2] [Reference Citation Analysis]
9 Vissers MFJM, Heuberger JAAC, Groeneveld GJ. Targeting for Success: Demonstrating Proof-of-Concept with Mechanistic Early Phase Clinical Pharmacology Studies for Disease-Modification in Neurodegenerative Disorders. Int J Mol Sci 2021;22:1615. [PMID: 33562713 DOI: 10.3390/ijms22041615] [Reference Citation Analysis]